We are live on
!
Find out more
SFI
Susquehanna Fundamental Investments Portfolio holdings
AUM
$2.67B
1-Year Est. Return
21.74%
This Fund
S&P 500
This Quarter
Est. Return
+6.56%
1 Year Est. Return
+21.74%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$2.04B
(+2,069%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
90.57%
Top 10 Holdings %
Top 10 Hldgs %
16.01%
Holding
701
New
636
Increased
22
Reduced
4
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$43.5M |
| 2 |
Pfizer
PFE
|
+$40.7M |
| 3 |
CVS Health
CVS
|
+$39.7M |
| 4 |
Philip Morris
PM
|
+$38.1M |
| 5 |
JPMorgan Chase
JPM
|
+$32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$20.3M |
| 2 |
Workday
WDAY
|
+$8.99M |
| 3 |
Ferguson
FERG
|
+$8.32M |
| 4 |
ANSS
Ansys
ANSS
|
+$5.21M |
| 5 |
Mercado Libre
MELI
|
+$4.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.3% |
| 2 | Industrials | 14.85% |
| 3 | Financials | 12.55% |
| 4 | Utilities | 10.01% |
| 5 | Consumer Staples | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
626
DELISTED
Verve Therapeutics
VERV
| $191K | 0.01% |
+14,370
| New | +$191K |
|
627
Granite Ridge Resources
GRNT
$674M
| $186K | 0.01% |
+28,602
| New | +$168K |
|
628
iHeartMedia
IHRT
$450M
| $181K | 0.01% |
+86,676
| New | +$204K |
|
629
Olema Pharmaceuticals
OLMA
$913M
| $176K | 0.01% |
+15,565
| New | +$201K |
|
630
Shattuck Labs
STTK
$752M
| $174K | 0.01% |
+19,415
| New | +$178K |
|
631
Sprinklr
CXM
$1.58B
| $166K | 0.01% |
+13,563
| New | +$173K |
|
632
Weave Communications
WEAV
$401M
| $156K | 0.01% |
+13,568
| New | +$163K |
|
633
Heritage Insurance Holdings
HRTG
$980M
| $155K | 0.01% |
+14,565
| New | +$103K |
|
634
BrightView Holdings
BV
$1.08B
| $155K | 0.01% |
+13,000
| New | +$118K |
|
635
Virgin Galactic
SPCE
$500M
| $151K | 0.01% |
+5,110
| New | +$185K |
|
|
CAN
636
Canaan Creative
CAN
$154M
| $149K | 0.01% |
+97,986
| New | +$166K |
|
637
Prime Medicine
PRME
$580M
| $148K | 0.01% |
+21,175
| New | +$161K |
|
638
Under Armour Class C
UA
$2.2B
| $145K | 0.01% |
+20,374
| New | +$156K |
|
639
DHT Holdings
DHT
$3.01B
| $144K | 0.01% |
+12,562
| New | +$138K |
|
|
OPI
640
DELISTED
Office Properties Income Trust
OPI
| $141K | 0.01% |
+69,196
| New | +$238K |
|
641
KLX Energy Services
KLXE
$35.1M
| $139K | 0.01% |
+17,970
| New | +$161K |
|
642
Alto Ingredients
ALTO
$315M
| $131K | 0.01% |
+59,929
| New | +$126K |
|
643
Adecoagro
AGRO
$1.34B
| $128K | 0.01% |
+11,600
| New | +$119K |
|
644
Relay Therapeutics
RLAY
$4.4B
| $127K | 0.01% |
+15,325
| New | +$150K |
|
645
CytomX Therapeutics
CTMX
$760M
| $124K | 0.01% |
+56,745
| New | +$105K |
|
|
ENFN
646
DELISTED
Enfusion, Inc.
ENFN
| $122K | 0.01% |
+13,214
| New | +$116K |
|
647
LivePerson
LPSN
$34.1M
| $122K | 0.01% |
+8,141
| New | +$280K |
|
648
Porch Group
PRCH
$1.83B
| $120K | 0.01% |
+27,863
| New | +$83.1K |
|
649
Definitive Healthcare
DH
$69.4M
| $120K | 0.01% |
+14,814
| New | +$131K |
|
650
WisdomTree
WT
$3.44B
| $118K | 0.01% |
+12,797
| New | +$98K |
|
Similar funds
TCAM
VA
MMEA
PCIG
MG
CCM
ACM
LP
Susquehanna Fundamental Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Susquehanna Fundamental Investments held 701 positions worth $2.14B, up 2,069% from $98.8M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Susquehanna Fundamental Investments deployed $1.94B of net new capital in Q1 2024, opening 636 new positions and adding to 22 existing holdings. Its largest new stake was Boeing: 211,714 shares worth $40.9M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 11% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Summit Therapeutics, an estimated $148K trimmed.
- Susquehanna Fundamental Investments's largest Q1 2024 buy was Boeing: 211,714 shares worth $40.9M.
- Susquehanna Fundamental Investments added most to Verisk Analytics in Q1 2024, an estimated $19.8M increase.
- Susquehanna Fundamental Investments's biggest Q1 2024 reduction was Summit Therapeutics, cutting an estimated $148K.
- Susquehanna Fundamental Investments fully exited Uber in Q1 2024, selling an estimated $20.3M.
- Susquehanna Fundamental Investments's ten largest holdings make up 16% of its $2.14B portfolio in Q1 2024.
- Susquehanna Fundamental Investments opened 636 new positions and closed 36 in Q1 2024.
- Susquehanna Fundamental Investments's portfolio value rose 2,069% quarter-over-quarter to $2.14B.
Based on Susquehanna Fundamental Investments's 13F filing for Q1 2024, filed 7 May 2024.